… In this evidence-synthesis study, we evaluated the effectiveness and safety among DOACs
for stroke prevention in patients with AF, using both the evidence from indirect and direct …

Background: Direct oral anticoagulants (DOACs) are increasingly used in place of warfarin,
but evidence about their effectiveness and safety in patients with valvular atrial fibrillation (AF…

… atrial fibrillation between January 1, 2011 (when dabigatran was approved as the first DOAC
for stroke prevention … ), before the diagnosis of atrial fibrillation. To restrict the cohort to NVAF…

… Whether direct oral anticoagulants (DOACs) are more effective and safer than warfarin
among Asian patients with non-valvular atrial fibrillation (NVAF) undergoing dialysis remains …

… AF is associated with a 3- to 5-fold increase in the risk of stroke, … anticoagulation, direct
oral anticoagulants (DOACs), in general, are recommended over warfarin for stroke prevention. …

… : Direct oral anticoagulants (DOACs) have been widely used in patients with atrial fibrillation
(AF) for antithrombotic prophylaxis, … The efficacy outcome was stroke or systemic embolism, …

… Oral anticoagulants, either vitamin K antagonists (VKA) such as warfarin, or direct oral
anticoagulants (DOACs) reduce that thromboembolic risk in atrial fibrillation (AF) patients by about …

… Oral Factor Xa Inhibitor” OR “direct oral anticoagulant” OR “non-vitamin K antagonist oral
anticoagulant… ” OR “vitamin K antagonist oral anticoagulant”) AND (“atrial fibrillation” OR “AF”) …

… Background: Direct oral anticoagulants (DOACs) have widely replaced … for stroke prevention
in nonvalvular atrial fibrillation. Our objective was to compare the safety and effectiveness of …

… atrial fibrillation (AF) carry a high risk of stroke … safety and effectiveness of anticoagulation
remains sparse. This study investigated the effectiveness and safety of direct oral anticoagulant …